NO963143L - Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne - Google Patents

Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne

Info

Publication number
NO963143L
NO963143L NO963143A NO963143A NO963143L NO 963143 L NO963143 L NO 963143L NO 963143 A NO963143 A NO 963143A NO 963143 A NO963143 A NO 963143A NO 963143 L NO963143 L NO 963143L
Authority
NO
Norway
Prior art keywords
oral drug
drug form
carries
preparation
active substances
Prior art date
Application number
NO963143A
Other languages
English (en)
Other versions
NO963143D0 (no
Inventor
Walter Muller
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO963143D0 publication Critical patent/NO963143D0/no
Publication of NO963143L publication Critical patent/NO963143L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oral legemiddelform med en bærer for surt virkestoff, hvorunder virkestoffet har minst en fri karboksylgruppe som er ionisk bundet til en polymer med tertiasre aminogrupper, er karakterisert ved at polymeren er colestipol hhv. colestipol- hydroklorid.
NO963143A 1994-01-27 1996-07-26 Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne NO963143L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung
PCT/EP1994/004082 WO1995020394A1 (de) 1994-01-27 1994-12-08 Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO963143D0 NO963143D0 (no) 1996-07-26
NO963143L true NO963143L (no) 1996-09-24

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963143A NO963143L (no) 1994-01-27 1996-07-26 Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne

Country Status (22)

Country Link
US (1) US5858344A (no)
EP (1) EP0741574B1 (no)
JP (1) JP3701971B2 (no)
KR (1) KR100439311B1 (no)
AT (1) ATE218371T1 (no)
AU (1) AU697353B2 (no)
CA (1) CA2182417C (no)
CZ (1) CZ291006B6 (no)
DE (2) DE4402379C2 (no)
DK (1) DK0741574T3 (no)
ES (1) ES2177622T3 (no)
FI (1) FI116880B (no)
HU (1) HU223317B1 (no)
IL (1) IL112435A (no)
MY (1) MY113340A (no)
NO (1) NO963143L (no)
NZ (1) NZ277777A (no)
PL (1) PL315619A1 (no)
PT (1) PT741574E (no)
SK (1) SK97296A3 (no)
WO (1) WO1995020394A1 (no)
ZA (1) ZA95638B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
IN2014DN03102A (no) 2006-11-07 2015-07-10 Procter & Gamble
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
EP4353762A1 (en) 2021-06-07 2024-04-17 University of Tsukuba Polymerized valproic acid and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
DE59410133D1 (de) 2002-07-11
PT741574E (pt) 2002-11-29
EP0741574A1 (de) 1996-11-13
ES2177622T3 (es) 2002-12-16
US5858344A (en) 1999-01-12
KR100439311B1 (ko) 2005-08-17
ATE218371T1 (de) 2002-06-15
JP3701971B2 (ja) 2005-10-05
NO963143D0 (no) 1996-07-26
FI962985A0 (fi) 1996-07-26
DE4402379A1 (de) 1995-08-03
PL315619A1 (en) 1996-11-25
DK0741574T3 (da) 2002-09-23
HUT74434A (en) 1996-12-30
MY113340A (en) 2002-01-31
IL112435A (en) 1999-01-26
AU697353B2 (en) 1998-10-01
NZ277777A (en) 1997-01-29
FI962985L (fi) 1996-07-26
CA2182417A1 (en) 1995-08-03
WO1995020394A1 (de) 1995-08-03
CZ221396A3 (en) 1997-01-15
CZ291006B6 (cs) 2002-11-13
HU9602041D0 (en) 1996-09-30
DE4402379C2 (de) 1997-09-25
FI116880B (fi) 2006-03-31
IL112435A0 (en) 1995-03-30
AU1312795A (en) 1995-08-15
EP0741574B1 (de) 2002-06-05
CA2182417C (en) 2007-04-17
ZA95638B (en) 1995-10-25
HU223317B1 (hu) 2004-05-28
KR970700505A (ko) 1997-02-12
JPH09511488A (ja) 1997-11-18
SK97296A3 (en) 1997-04-09

Similar Documents

Publication Publication Date Title
BR9910404A (pt) Sistema terapêutico transdérmico (tts) para administração transcutânea de pergolide por vários dias com um meio de fixar o tts sobre a pele
DE3687458D1 (de) Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
ES2114183T3 (es) Anticuerpo para el tratamiento de la diabetes dependiente de la insulina.
DK132287A (da) Anvendelse af n-substitueret isobutyramid i racemisk (r,s)-form eller i venstredrejende optisk aktiv (s)-form eller et salt heraf til fremstilling af et laegemiddel mod obesitet
DK164205C (da) Sikkerhedsindretning til at forbinde en sproejte med mundingen paa en flaske som indeholder et medikament
NO893999D0 (no) Beskyttelsesanordning for kanyle til blodproever.
DK407588D0 (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse
ATE67930T1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
NO891680D0 (no) Osmotisk kontinuerlig avgivende oralt avgivelsessystem inneholdende et farmasoeytisk akseptabelt aktivt middel som har forbedrede kjernemembran-adhesjonsegenskaper.
ES2164215T3 (es) Comprimidos de aspirina estabilizados recubiertos con gelatina.
DE69410630D1 (de) Vorrichtung zur frühembryonalen in ovo injektion
DK0825178T3 (da) Phenylsubstituerede alkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
NO963143L (no) Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne
DK299089D0 (da) Anvendelse af prostaglandiner til fremstilling af laegemidler
DK181889D0 (da) Forbedret fremgangsmaade til omdannelse af ikke-traeagtige lignocellulosesubstrater til produkter til droevtyggere
IT8447630A0 (it) Dispositivo medico per la riparazione senza sutura di nervi lacerati, recisi o innestati e procedimentodi preparazione
DE68907053D1 (de) Grundierungs/membranabdichtungssystem.
FI913034A7 (fi) Yhdiste, jolla on vatsahappoa inhiboiva vaikutus, ja menetelmä sen val mistamiseksi
PT90661A (pt) Processo para a preparacao de composicoes farmaceuticas contendo inibidores da enzima conversora de angiotensina e moduladores de canal de potassio
DK602987A (da) Optisk aktive gyrasehaemmere, fremgangsmaade til deres fremstilling samt deres anvendelse som antibiotika
ID17348A (id) 1-naftoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya
NO890803D0 (no) Fremgangsmaate for fremstilling av trisubstituerte aminer.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.